S
Sverre E. Kjeldsen
Researcher at University of Oslo
Publications - 771
Citations - 95426
Sverre E. Kjeldsen is an academic researcher from University of Oslo. The author has contributed to research in topics: Blood pressure & Left ventricular hypertrophy. The author has an hindex of 94, co-authored 735 publications receiving 89059 citations. Previous affiliations of Sverre E. Kjeldsen include University of Michigan & Cornell University.
Papers
More filters
Journal ArticleDOI
What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist?
Maciej Banach,Marta Michalska,Sverre E. Kjeldsen,Jolanta Malyszko,Dimitri P. Mikhailidis,Jacek Rysz +5 more
TL;DR: It seems that in high-risk patients with hypertension, it is necessary to carefully select those who might suffer adverse events and those who may benefit from intensive BP lowering, because this may be associated with more cardiovascular events.
Journal ArticleDOI
Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.
TL;DR: There is a large consensus on the need to further study catheter-based renal denervation in more controlled conditions, with particular emphasis on identification of predictors of blood pressure response.
Journal ArticleDOI
Physician (investigator) inertia in apparent treatment-resistant hypertension - insights from large randomized clinical trials. Lennart Hansson Memorial Lecture.
TL;DR: Monitoring data from monitoring phases of large outcome trials in hypertension show that inertia, the lack of titration of study drugs to higher dosing levels or drug combinations according to the study protocols, is a major cause of not reaching BP targets in the trials.
Journal ArticleDOI
Serum Uric Acid is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study
Benedicte P. Wiik,Anne Cecilie K Larstorp,Aud Høieggen,Sverre E. Kjeldsen,Sverre E. Kjeldsen,Michael H. Olsen,Hans Ibsen,Lars H Lindholm,Björn Dahlöf,Richard B. Devereux,Peter M. Okin,Kristian Wachtell +11 more
TL;DR: The analysis suggests that SUA is an independent risk marker for NOD in hypertensive patients with LVH.
Journal ArticleDOI
Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension
Lotte Jacobs,Alexandre Persu,Qi-Fang Huang,Jean-Philippe Lengelé,Lutgarde Thijs,Frank Hammer,Wen-Yi Yang,Zhenyu Zhang,Jean Renkin,Peter Sinnaeve,Fang-Fei Wei,Agnes Pasquet,Fadl Elmula M. Fadl Elmula,Marc Carlier,Arif Elvan,Cora Wunder,Sverre E. Kjeldsen,Stefan W. Toennes,Stefan Janssens,Peter Verhamme,Jan A. Staessen +20 more
TL;DR: The INSPiRED pilot suggests that RDN with the EnligHTN™ system is effective and safe and generated insights useful for the design of future RDN trials.